CervoMed Inc. - Common Stock, $0.001 par value (CRVO)

CUSIP: 15713L109

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 6 signals
Share change
+929,644
SEC-reported price per share
$17.12
Indexed holders
38
Value change
+$15,847,476
Number of buys
26
Number of sells
5
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
16,714,197

Security key

15713L109

Report period

Q2 2024

Indexed institutions

38

Top holders

10

Ownership snapshot

Top reported holders of CRVO - CervoMed Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F Highest disclosed value: $20,074,651 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $20.07M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
RA CAPITAL MANAGEMENT, L.P. $20.07M
ARMISTICE CAPITAL, LLC $17.11M
Ikarian Capital, LLC $5.53M
ADAGE CAPITAL PARTNERS GP, L.L.C. $4.64M
Soleus Capital Management, L.P. $2.95M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$20,074,651
861,573 shares
— 31 Mar 2024
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$17,110,658
734,363 shares
— 31 Mar 2024
Ikarian Capital, LLC
13F
Company
13F
—
denominator unverified
$5,530,138
237,345 shares
— 31 Mar 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
—
denominator unverified
$4,644,785
199,347 shares
— 31 Mar 2024
Soleus Capital Management, L.P.
13F
Company
13F
—
denominator unverified
$2,950,106
126,614 shares
— 31 Mar 2024
CROWN ADVISORS MANAGEMENT, INC.
13F
Company
13F
—
denominator unverified
$2,330,000
100,000 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
38
Shares
3,446,957
Indexed holders
38
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 indexed holders
20
Q2 2024 indexed holders
38
Indexed holder difference
18
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .